Ted Driscoll

Claremont Creek Ventures (Claremont Creek) is a venture capital firm founded in 2005 by Nat Goldhaber, Randy Hawks and John Steuart. The firm is headquartered in Oakland, California.

NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA.

Novus Ventures (Novus Ventures) is a venture capital firm founded in 1994 by Dan Tompkins. The firm is headquartered in Cupertino, California.

Part of Sonablate Corp., Focus Surgery, Inc. develops products using High Intensity Focused Ultrasound (HIFU) for the treatment of cancer and soft tissue diseases. The company is based in Indianapolis, IN. The company was founded by Narendra T. Sanghvi. Focus Surgery was acquired by Sonablate Corp. on July 02, 2008.

Sand Hill Angels Inc (Sand Hill Angels) is an angel investment firm founded in 2000. The firm is headquartered in Mountain View, California.

Tibion Corp. designs and develops medical devices. It develops innovative equipment that helps individuals recover physical function lost due to disease, trauma or aging. The company was founded was founded by Kern Bhugra and Robert Horst in 2002 and is headquartered in Sunnyvale, CA.

Part of GE Healthcare Technologies, Inc., OEC Medical Systems, Inc. is a company that develops, sells, and services X-ray and fluoroscopic imaging systems. The company is based in Salt Lake City, UT. The company was founded in 1942 by Al S. Waxman. OEC Medical Systems was acquired by GE Medical Systems, Inc. on November 29, 1999 for $444.47 million.

GigaGen, Inc. engages in the provision of single cell droplet technology to clinical researchers and physicians. The firm's patent-pending technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize genetic data from cells circulating in blood. Its technology can be applied in immunology, infectious disease monitoring, noninvasive prenatal diagnostics, and noninvasive cancer detection. The company was founded by David S. Johnson and Everett Meyer in 2010 and is headquartered in South San Francisco, CA.

Therus Corp. develops a noninvasive high intensity focused ultrasound device to quickly, safely and easily close femoral access sites following interventional cardiology procedures